A study on periostin involvement in the pathophysiology of canine atopic skin

Atopic dermatitis (AD) is a chronic, pruritic, and allergic skin disease in humans and animals, particularly dogs. Canine AD (cAD) has received attention as a spontaneous atopic animal model because domesticated dogs inhabit a human environment, and cAD shares several clinicopathological features wi...

Full description

Saved in:
Bibliographic Details
Published inJournal of Veterinary Medical Science Vol. 80; no. 1; pp. 103 - 111
Main Authors MINESHIGE, Takayuki, KAMIIE, Junichi, SUGAHARA, Go, SHIROTA, Kinji
Format Journal Article
LanguageEnglish
Published Japan JAPANESE SOCIETY OF VETERINARY SCIENCE 01.01.2018
Japan Science and Technology Agency
The Japanese Society of Veterinary Science
Subjects
Online AccessGet full text

Cover

Loading…
Abstract Atopic dermatitis (AD) is a chronic, pruritic, and allergic skin disease in humans and animals, particularly dogs. Canine AD (cAD) has received attention as a spontaneous atopic animal model because domesticated dogs inhabit a human environment, and cAD shares several clinicopathological features with human AD (hAD). In hAD, periostin (PO) is suggested to play a critical role in the enhancement and chronicity of allergic skin inflammation; however, PO involvement in the pathogenesis of cAD is unknown. Here we aimed to clarify PO involvement in the pathophysiology of cAD and focused on the inducing factor and function of PO in canine atopic skin. Using double-labeled in situ hybridization (ISH), interleukin (IL)-13 mRNA-positive cells were detected near the keratinocytes and dermal fibroblasts expressing PO mRNA in atopic skin. Using an in vitro assay, IL-13 induced PO gene expression in both canine dermal fibroblasts and keratinocytes. PO enhanced in vitro growth of canine keratinocytes. Moreover, among PO-induced genes in cultured canine keratinocytes detected using a microarray, we identified IL-25 as a possible mediator in canine atopic skin. In addition, real time polymerase chain reaction (PCR) analysis revealed upregulation of IL-25 gene expression in PO-stimulated keratinocytes. These data suggest that IL-13 possibly derived from T helper 2 (Th2) cells stimulates PO production in both keratinocytes and fibroblasts, and then PO may play a critical role in the pathophysiology of cAD, particularly in the enhancement and chronicity of skin lesions via IL-25.
AbstractList Atopic dermatitis (AD) is a chronic, pruritic, and allergic skin disease in humans and animals, particularly dogs. Canine AD (cAD) has received attention as a spontaneous atopic animal model because domesticated dogs inhabit a human environment, and cAD shares several clinicopathological features with human AD (hAD). In hAD, periostin (PO) is suggested to play a critical role in the enhancement and chronicity of allergic skin inflammation; however, PO involvement in the pathogenesis of cAD is unknown. Here we aimed to clarify PO involvement in the pathophysiology of cAD and focused on the inducing factor and function of PO in canine atopic skin. Using double-labeled in situ hybridization (ISH), interleukin (IL)-13 mRNA-positive cells were detected near the keratinocytes and dermal fibroblasts expressing PO mRNA in atopic skin. Using an in vitro assay, IL-13 induced PO gene expression in both canine dermal fibroblasts and keratinocytes. PO enhanced in vitro growth of canine keratinocytes. Moreover, among PO-induced genes in cultured canine keratinocytes detected using a microarray, we identified IL-25 as a possible mediator in canine atopic skin. In addition, real time polymerase chain reaction (PCR) analysis revealed upregulation of IL-25 gene expression in PO-stimulated keratinocytes. These data suggest that IL-13 possibly derived from T helper 2 (Th2) cells stimulates PO production in both keratinocytes and fibroblasts, and then PO may play a critical role in the pathophysiology of cAD, particularly in the enhancement and chronicity of skin lesions via IL-25.
Atopic dermatitis (AD) is a chronic, pruritic, and allergic skin disease in humans and animals, particularly dogs. Canine AD (cAD) has received attention as a spontaneous atopic animal model because domesticated dogs inhabit a human environment, and cAD shares several clinicopathological features with human AD (hAD). In hAD, periostin (PO) is suggested to play a critical role in the enhancement and chronicity of allergic skin inflammation; however, PO involvement in the pathogenesis of cAD is unknown. Here we aimed to clarify PO involvement in the pathophysiology of cAD and focused on the inducing factor and function of PO in canine atopic skin. Using double-labeled in situ hybridization (ISH), interleukin (IL)-13 mRNA-positive cells were detected near the keratinocytes and dermal fibroblasts expressing PO mRNA in atopic skin. Using an in vitro assay, IL-13 induced PO gene expression in both canine dermal fibroblasts and keratinocytes. PO enhanced in vitro growth of canine keratinocytes. Moreover, among PO-induced genes in cultured canine keratinocytes detected using a microarray, we identified IL-25 as a possible mediator in canine atopic skin. In addition, real time polymerase chain reaction (PCR) analysis revealed upregulation of IL-25 gene expression in PO-stimulated keratinocytes. These data suggest that IL-13 possibly derived from T helper 2 (Th2) cells stimulates PO production in both keratinocytes and fibroblasts, and then PO may play a critical role in the pathophysiology of cAD, particularly in the enhancement and chronicity of skin lesions via IL-25.Atopic dermatitis (AD) is a chronic, pruritic, and allergic skin disease in humans and animals, particularly dogs. Canine AD (cAD) has received attention as a spontaneous atopic animal model because domesticated dogs inhabit a human environment, and cAD shares several clinicopathological features with human AD (hAD). In hAD, periostin (PO) is suggested to play a critical role in the enhancement and chronicity of allergic skin inflammation; however, PO involvement in the pathogenesis of cAD is unknown. Here we aimed to clarify PO involvement in the pathophysiology of cAD and focused on the inducing factor and function of PO in canine atopic skin. Using double-labeled in situ hybridization (ISH), interleukin (IL)-13 mRNA-positive cells were detected near the keratinocytes and dermal fibroblasts expressing PO mRNA in atopic skin. Using an in vitro assay, IL-13 induced PO gene expression in both canine dermal fibroblasts and keratinocytes. PO enhanced in vitro growth of canine keratinocytes. Moreover, among PO-induced genes in cultured canine keratinocytes detected using a microarray, we identified IL-25 as a possible mediator in canine atopic skin. In addition, real time polymerase chain reaction (PCR) analysis revealed upregulation of IL-25 gene expression in PO-stimulated keratinocytes. These data suggest that IL-13 possibly derived from T helper 2 (Th2) cells stimulates PO production in both keratinocytes and fibroblasts, and then PO may play a critical role in the pathophysiology of cAD, particularly in the enhancement and chronicity of skin lesions via IL-25.
Atopic dermatitis (AD) is a chronic, pruritic, and allergic skin disease in humans and animals, particularly dogs. Canine AD (cAD) has received attention as a spontaneous atopic animal model because domesticated dogs inhabit a human environment, and cAD shares several clinicopathological features with human AD (hAD). In hAD, periostin (PO) is suggested to play a critical role in the enhancement and chronicity of allergic skin inflammation; however, PO involvement in the pathogenesis of cAD is unknown. Here we aimed to clarify PO involvement in the pathophysiology of cAD and focused on the inducing factor and function of PO in canine atopic skin. Using double-labeled in situ hybridization (ISH), interleukin (IL)-13 mRNA-positive cells were detected near the keratinocytes and dermal fibroblasts expressing PO mRNA in atopic skin. Using an in vitro assay, IL-13 induced PO gene expression in both canine dermal fibroblasts and keratinocytes. PO enhanced in vitro growth of canine keratinocytes. Moreover, among PO-induced genes in cultured canine keratinocytes detected using a microarray, we identified IL-25 as a possible mediator in canine atopic skin. In addition, real time polymerase chain reaction (PCR) analysis revealed upregulation of IL-25 gene expression in PO-stimulated keratinocytes. These data suggest that IL-13 possibly derived from T helper 2 (Th2) cells stimulates PO production in both keratinocytes and fibroblasts, and then PO may play a critical role in the pathophysiology of cAD, particularly in the enhancement and chronicity of skin lesions via IL-25.
Author MINESHIGE, Takayuki
SHIROTA, Kinji
KAMIIE, Junichi
SUGAHARA, Go
Author_xml – sequence: 1
  fullname: MINESHIGE, Takayuki
  organization: Laboratory of Veterinary Pathology, School of Veterinary Medicine, Azabu University, 1-17-71 Fuchinobe, Chuo-ku, Sagamihara, Kanagawa 252-5201, Japan
– sequence: 2
  fullname: KAMIIE, Junichi
  organization: Laboratory of Veterinary Pathology, School of Veterinary Medicine, Azabu University, 1-17-71 Fuchinobe, Chuo-ku, Sagamihara, Kanagawa 252-5201, Japan
– sequence: 3
  fullname: SUGAHARA, Go
  organization: Laboratory of Veterinary Pathology, School of Veterinary Medicine, Azabu University, 1-17-71 Fuchinobe, Chuo-ku, Sagamihara, Kanagawa 252-5201, Japan
– sequence: 4
  fullname: SHIROTA, Kinji
  organization: Laboratory of Veterinary Pathology, School of Veterinary Medicine, Azabu University, 1-17-71 Fuchinobe, Chuo-ku, Sagamihara, Kanagawa 252-5201, Japan
BackLink https://www.ncbi.nlm.nih.gov/pubmed/29176263$$D View this record in MEDLINE/PubMed
BookMark eNp1kc9rFDEUx4NU7LZ68ywDXjx0an7MJJuLUItVoeJFzyGTfdnNOpOMSWZh_3szTl20IIEk8D7fb74v7wKd-eABoZcEXxMq6dv9YUjXRNS4adkTtCKsEbVomDxDKywJrwVt8Tm6SGmPMSUNl8_QOZVEcMrZCn25qVKeNscq-GqE6ELKzlfOH0J_gAF8Lvcq76Aadd6FcXdMLvRhW3hbGe2dh0rnMDpTpR_OP0dPre4TvHg4L9H3uw_fbj_V918_fr69ua8N5zTXZM26rtPUNlh0nWiMZI01FAiBhqyFlXbTyYZTbbRlLcegJRhsbGcY2NYYdoneLb7j1A2wMSVn1L0aoxt0PKqgnfq34t1ObcNBtUKKNRfF4M2DQQw_J0hZDS4Z6HvtIUxJEcmlZFy2sqCvH6H7MEVf2lOUMslJWbPhq78TnaL8-ekCXC2AiSGlCPaEEKzmQap5kIoINQ-y4PQRblzW2YW5H9f_T_R-Ee1T1ls4vaBjdqaHBV4X5e9tEZ2KZqejAs9-AeSNvE8
CitedBy_id crossref_primary_10_1111_vde_13192
crossref_primary_10_1590_s1519_99402122242021
crossref_primary_10_1292_jvms_17_0647
crossref_primary_10_3390_vetsci8070124
crossref_primary_10_1016_j_phymed_2021_153679
crossref_primary_10_1111_vde_13324
crossref_primary_10_1111_vde_13156
crossref_primary_10_3390_vetsci12010004
crossref_primary_10_1016_j_cvsm_2024_11_002
crossref_primary_10_1007_s00204_020_02875_3
crossref_primary_10_1016_j_celrep_2020_03_036
crossref_primary_10_1186_s13601_018_0228_5
Cites_doi 10.1038/jid.2009.133
10.1007/s00428-011-1151-5
10.1016/j.vetimm.2004.08.021
10.1016/j.jaci.2014.11.017
10.1042/bj2940271
10.1111/j.1365-2222.2011.03840.x
10.1016/S0165-2427(01)00305-1
10.1007/s12079-010-0090-2
10.1111/j.1600-0625.1999.tb00372.x
10.1016/j.jaci.2006.02.046
10.2332/allergolint.13-RAI-0685
10.1242/jcs.087841
10.1038/jid.2009.98
10.1016/j.vetimm.2011.05.025
10.1172/JCI58978
10.1016/S0165-2427(96)05763-7
10.1084/jem.20070406
10.1038/jid.2010.277
10.1074/jbc.275.20.15220
10.1046/j.1365-3164.2003.00335.x
10.1056/NEJMoa1106469
10.1016/j.jdermsci.2013.08.010
10.1016/j.jaci.2014.05.029
ContentType Journal Article
Copyright 2018 by the Japanese Society of Veterinary Science
Copyright Japan Science and Technology Agency Jan 2018
2018 The Japanese Society of Veterinary Science 2018
Copyright_xml – notice: 2018 by the Japanese Society of Veterinary Science
– notice: Copyright Japan Science and Technology Agency Jan 2018
– notice: 2018 The Japanese Society of Veterinary Science 2018
DBID AAYXX
CITATION
CGR
CUY
CVF
ECM
EIF
NPM
7QR
7U9
8FD
FR3
H94
M7N
P64
7X8
5PM
DOI 10.1292/jvms.17-0453
DatabaseName CrossRef
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
Chemoreception Abstracts
Virology and AIDS Abstracts
Technology Research Database
Engineering Research Database
AIDS and Cancer Research Abstracts
Algology Mycology and Protozoology Abstracts (Microbiology C)
Biotechnology and BioEngineering Abstracts
MEDLINE - Academic
PubMed Central (Full Participant titles)
DatabaseTitle CrossRef
MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
Virology and AIDS Abstracts
Technology Research Database
Algology Mycology and Protozoology Abstracts (Microbiology C)
AIDS and Cancer Research Abstracts
Chemoreception Abstracts
Engineering Research Database
Biotechnology and BioEngineering Abstracts
MEDLINE - Academic
DatabaseTitleList Virology and AIDS Abstracts
MEDLINE
MEDLINE - Academic


Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
Discipline Veterinary Medicine
EISSN 1347-7439
EndPage 111
ExternalDocumentID PMC5797867
29176263
10_1292_jvms_17_0453
article_jvms_80_1_80_17_0453_article_char_en
Genre Journal Article
GroupedDBID 29L
2WC
53G
5GY
ACGFO
ACIWK
ACPRK
ADBBV
ADRAZ
AENEX
AFRAH
AI.
ALMA_UNASSIGNED_HOLDINGS
AOIJS
BAWUL
CS3
DIK
DU5
E3Z
EBS
EJD
HYE
JSF
JSH
KQ8
M48
M~E
N5S
OK1
P2P
RJT
RNS
RPM
RYR
RZJ
TKC
TR2
VH1
XSB
AAYXX
B.T
CITATION
OVT
PGMZT
CGR
CUY
CVF
ECM
EIF
NPM
7QR
7U9
8FD
FR3
H94
M7N
P64
7X8
5PM
ID FETCH-LOGICAL-c662t-183bbba2f407bb74c934fc2e11e4187f9fdb9462acaf3560ea9ec0cfbc3ef5cc3
IEDL.DBID M48
ISSN 0916-7250
1347-7439
IngestDate Thu Aug 21 14:13:58 EDT 2025
Fri Jul 11 09:58:08 EDT 2025
Mon Jun 30 11:10:55 EDT 2025
Wed Feb 19 02:42:17 EST 2025
Tue Jul 01 04:14:33 EDT 2025
Thu Apr 24 22:53:19 EDT 2025
Wed Apr 05 08:57:02 EDT 2023
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 1
Keywords interleukin-25
atopic dermatitis
periostin
dog
interleukin-13
Language English
License This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial No Derivatives (by-nc-nd) License. (CC-BY-NC-ND 4.0: https://creativecommons.org/licenses/by-nc-nd/4.0/)
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c662t-183bbba2f407bb74c934fc2e11e4187f9fdb9462acaf3560ea9ec0cfbc3ef5cc3
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 14
content type line 23
OpenAccessLink http://journals.scholarsportal.info/openUrl.xqy?doi=10.1292/jvms.17-0453
PMID 29176263
PQID 2239616167
PQPubID 2028964
PageCount 9
ParticipantIDs pubmedcentral_primary_oai_pubmedcentral_nih_gov_5797867
proquest_miscellaneous_1969936959
proquest_journals_2239616167
pubmed_primary_29176263
crossref_primary_10_1292_jvms_17_0453
crossref_citationtrail_10_1292_jvms_17_0453
jstage_primary_article_jvms_80_1_80_17_0453_article_char_en
ProviderPackageCode CITATION
AAYXX
PublicationCentury 2000
PublicationDate 2018-01-01
PublicationDateYYYYMMDD 2018-01-01
PublicationDate_xml – month: 01
  year: 2018
  text: 2018-01-01
  day: 01
PublicationDecade 2010
PublicationPlace Japan
PublicationPlace_xml – name: Japan
– name: Tokyo
PublicationTitle Journal of Veterinary Medical Science
PublicationTitleAlternate J. Vet. Med. Sci.
PublicationYear 2018
Publisher JAPANESE SOCIETY OF VETERINARY SCIENCE
Japan Science and Technology Agency
The Japanese Society of Veterinary Science
Publisher_xml – name: JAPANESE SOCIETY OF VETERINARY SCIENCE
– name: Japan Science and Technology Agency
– name: The Japanese Society of Veterinary Science
References 1. Abraham, D. J., Shiwen, X., Black, C. M., Sa, S., Xu, Y. and Leask, A. 2000. Tumor necrosis factor alpha suppresses the induction of connective tissue growth factor by transforming growth factor-beta in normal and scleroderma fibroblasts. J. Biol. Chem. 275: 15220–15225.
22. Sinke, J. D., Thepen, T., Bihari, I. C., Rutten, V. P. and Willemse, T. 1997. Immunophenotyping of skin-infiltrating T-cell subsets in dogs with atopic dermatitis. Vet. Immunol. Immunopathol. 57: 13–23.
23. Takayama, G., Arima, K., Kanaji, T., Toda, S., Tanaka, H., Shoji, S., McKenzie, A. N., Nagai, H., Hotokebuchi, T. and Izuhara, K. 2006. Periostin: a novel component of subepithelial fibrosis of bronchial asthma downstream of IL-4 and IL-13 signals. J. Allergy Clin. Immunol. 118: 98–104.
8. Fort, M. M., Cheung, J., Yen, D., Li, J., Zurawski, S. M., Lo, S., Menon, S., Clifford, T., Hunte, B., Lesley, R., Muchamuel, T., Hurst, S. D., Zurawski, G., Leach, M. W., Gorman, D. M. and Rennick, D. M. 2001. IL-25 induces IL-4, IL-5, and IL-13 and Th2-associated pathologies in vivo. Immunity 15: 985–995.
27. Wang, Y. H., Angkasekwinai, P., Lu, N., Voo, K. S., Arima, K., Hanabuchi, S., Hippe, A., Corrigan, C. J., Dong, C., Homey, B., Yao, Z., Ying, S., Huston, D. P. and Liu, Y. J. 2007. IL-25 augments type 2 immune responses by enhancing the expansion and functions of TSLP-DC-activated Th2 memory cells. J. Exp. Med. 204: 1837–1847.
4. Corren, J., Lemanske, R. F. Jr., Hanania, N. A., Korenblat, P. E., Parsey, M. V., Arron, J. R., Harris, J. M., Scheerens, H., Wu, L. C., Su, Z., Mosesova, S., Eisner, M. D., Bohen, S. P. and Matthews, J. G. 2011. Lebrikizumab treatment in adults with asthma. N. Engl. J. Med. 365: 1088–1098.
17. Olivry, T. and Hill, P. B. 2001. The ACVD task force on canine atopic dermatitis (XVIII): histopathology of skin lesions. Vet. Immunol. Immunopathol. 81: 305–309.
3. Cork, M. J., Danby, S. G., Vasilopoulos, Y., Hadgraft, J., Lane, M. E., Moustafa, M., Guy, R. H., Macgowan, A. L., Tazi-Ahnini, R. and Ward, S. J. 2009. Epidermal barrier dysfunction in atopic dermatitis. J. Invest. Dermatol. 129: 1892–1908.
14. Masuoka, M., Shiraishi, H., Ohta, S., Suzuki, S., Arima, K., Aoki, S., Toda, S., Inagaki, N., Kurihara, Y., Hayashida, S., Takeuchi, S., Koike, K., Ono, J., Noshiro, H., Furue, M., Conway, S. J., Narisawa, Y. and Izuhara, K. 2012. Periostin promotes chronic allergic inflammation in response to Th2 cytokines. J. Clin. Invest. 122: 2590–2600.
5. Correa da Rosa, J., Malajian, D., Shemer, A., Rozenblit, M., Dhingra, N., Czarnowicki, T., Khattri, S., Ungar, B., Finney, R., Xu, H., Zheng, X., Estrada, Y. D., Peng, X., Suárez-Fariñas, M., Krueger, J. G. and Guttman-Yassky, E. 2015. Patients with atopic dermatitis have attenuated and distinct contact hypersensitivity responses to common allergens in skin. J. Allergy Clin. Immunol. 135: 712–720.
13. Marsella, R. and Girolomoni, G. 2009. Canine models of atopic dermatitis: a useful tool with untapped potential. J. Invest. Dermatol. 129: 2351–2357.
12. Maeda, S., Tsukui, T., Saze, K., Masuda, K., Ohno, K., Tsujimoto, H. and Iwabuchi, S. 2005. Production of a monoclonal antibody to canine thymus and activation-regulated chemokine (TARC) and detection of TARC in lesional skin from dogs with atopic dermatitis. Vet. Immunol. Immunopathol. 103: 83–92.
26. Tsuchida, S., Bonkobara, M., McMillan, J. R., Akiyama, M., Yudate, T., Aragane, Y., Tezuka, T., Shimizu, H., Cruz, P. D. Jr. and Ariizumi, K. 2004. Characterization of Kdap, a protein secreted by keratinocytes. J. Invest. Dermatol. 122: 1225–1234.
7. Elliott, C. G., Wang, J., Guo, X., Xu, S. W., Eastwood, M., Guan, J., Leask, A., Conway, S. J. and Hamilton, D. W. 2012. Periostin modulates myofibroblast differentiation during full-thickness cutaneous wound repair. J. Cell Sci. 125: 121–132.
21. Schlotter, Y. M., Rutten, V. P., Riemers, F. M., Knol, E. F. and Willemse, T. 2011. Lesional skin in atopic dogs shows a mixed Type-1 and Type-2 immune responsiveness. Vet. Immunol. Immunopathol. 143: 20–26.
6. Egbert, M., Ruetze, M., Sattler, M., Wenck, H., Gallinat, S., Lucius, R. and Weise, J. M. 2014. The matricellular protein periostin contributes to proper collagen function and is downregulated during skin aging. J. Dermatol. Sci. 73: 40–48.
10. Gordon, E. D., Sidhu, S. S., Wang, Z. E., Woodruff, P. G., Yuan, S., Solon, M. C., Conway, S. J., Huang, X., Locksley, R. M. and Fahy, J. V. 2012. A protective role for periostin and TGF-β in IgE-mediated allergy and airway hyperresponsiveness. Clin. Exp. Allergy 42: 144–155.
19. Olivry, T., Dean, G. A., Tompkins, M. B., Dow, J. L. and Moore, P. F. 1999. Toward a canine model of atopic dermatitis: amplification of cytokine-gene transcripts in the skin of atopic dogs. Exp. Dermatol. 8: 204–211.
11. Hvid, M., Vestergaard, C., Kemp, K., Christensen, G. B., Deleuran, B. and Deleuran, M. 2011. IL-25 in atopic dermatitis: a possible link between inflammation and skin barrier dysfunction? J. Invest. Dermatol. 131: 150–157.
15. Mineshige, T., Kamiie, J., Sugahara, G., Yasuno, K., Aihara, N., Kawarai, S., Yamagishi, K., Shirota, M. and Shirota, K. 2015. Expression of Periostin in Normal, Atopic, and Nonatopic Chronically Inflamed Canine Skin. Vet. Pathol. 52: 1118–1126.
25. Terada, Y., Nagata, M., Murayama, N., Nanko, H. and Furue, M. 2011. Clinical comparison of human and canine atopic dermatitis using human diagnostic criteria (Japanese Dermatological Association, 2009): proposal of provisional diagnostic criteria for canine atopic dermatitis. J. Dermatol. 38: 784–790.
29. Yamaguchi, Y. 2014. Periostin in Skin Tissue and Skin-Related Diseases. Allergol. Int. 63: 161–170.
9. Gillan, L., Matei, D., Fishman, D. A., Gerbin, C. S., Karlan, B. Y. and Chang, D. D. 2002. Periostin secreted by epithelial ovarian carcinoma is a ligand for alpha(V)beta(3) and alpha(V)beta(5) integrins and promotes cell motility. Cancer Res. 62: 5358–5364.
24. Takeshita, S., Kikuno, R., Tezuka, K. and Amann, E. 1993. Osteoblast-specific factor 2: cloning of a putative bone adhesion protein with homology with the insect protein fasciclin I. Biochem. J. 294: 271–278.
28. Yagihara, H., Kinjo, E., Kobayashi, Y., Tsuji, A., Nishimura, Y., Shinozaki, N., Tamura, K., Isotani, M., Nakagaki, K., Takahashi, K., Ono, K., Washizu, T. and Bonkobara, M. 2009. Expression of canine Kdap in normal, hyperplastic and neoplastic epidermis. Vet. J. 180: 348–355.
18. Olivry, T. and Mueller, R. S.International Task Force on Canine Atopic Dermatitis 2003. Evidence-based veterinary dermatology: a systematic review of the pharmacotherapy of canine atopic dermatitis. Vet. Dermatol. 14: 121–146.
2. Bentley, J. K., Chen, Q., Hong, J. Y., Popova, A. P., Lei, J., Moore, B. B. and Hershenson, M. B. 2014. Periostin is required for maximal airways inflammation and hyperresponsiveness in mice. J. Allergy Clin. Immunol. 134: 1433–1442.
16. Morra, L. and Moch, H. 2011. Periostin expression and epithelial-mesenchymal transition in cancer: a review and an update. Virchows Arch. 459: 465–475.
30. Zhou, H. M., Wang, J., Elliott, C., Wen, W., Hamilton, D. W. and Conway, S. J. 2010. Spatiotemporal expression of periostin during skin development and incisional wound healing: lessons for human fibrotic scar formation. J. Cell Commun. Signal. 4: 99–107.
20. Rios, H., Koushik, S. V., Wang, H., Wang, J., Zhou, H. M., Lindsley, A., Rogers, R., Chen, Z., Maeda, M., Kruzynska-Frejtag, A., Feng, J. Q. and Conway, S. J. 2005. periostin null mice exhibit dwarfism, incisor enamel defects, and an early-onset periodontal disease-like phenotype. Mol. Cell. Biol. 25: 11131–11144.
22
23
24
25
26
27
28
29
30
10
11
12
13
14
15
16
17
18
19
1
2
3
4
5
6
7
8
9
20
21
8363580 - Biochem J. 1993 Aug 15;294 ( Pt 1):271-8
21434981 - J Dermatol. 2011 Aug;38(8):784-90
15140226 - J Invest Dermatol. 2004 May;122(5):1225-34
21684616 - Vet Immunol Immunopathol. 2011 Sep 15;143(1-2):20-6
21997759 - Virchows Arch. 2011 Nov;459(5):465-75
19494826 - J Invest Dermatol. 2009 Aug;129(8):1892-908
20531985 - J Cell Commun Signal. 2010 Jun;4(2):99-107
10809757 - J Biol Chem. 2000 May 19;275(20):15220-5
21812663 - N Engl J Med. 2011 Sep 22;365(12 ):1088-98
25755133 - Vet Pathol. 2015 Nov;52(6):1118-26
17635955 - J Exp Med. 2007 Aug 6;204(8):1837-47
20861853 - J Invest Dermatol. 2011 Jan;131(1):150-7
12791047 - Vet Dermatol. 2003 Jun;14(3):121-46
24759560 - Allergol Int. 2014 Jun;63(2):161-70
16314533 - Mol Cell Biol. 2005 Dec;25(24):11131-44
24055232 - J Dermatol Sci. 2014 Jan;73(1):40-8
11553392 - Vet Immunol Immunopathol. 2001 Sep 20;81(3-4):305-9
11754819 - Immunity. 2001 Dec;15(6):985-95
22266908 - J Cell Sci. 2012 Jan 1;125(Pt 1):121-32
12235007 - Cancer Res. 2002 Sep 15;62(18):5358-64
24996263 - J Allergy Clin Immunol. 2014 Dec;134(6):1433-1442
25583101 - J Allergy Clin Immunol. 2015 Mar;135(3):712-20
22684102 - J Clin Invest. 2012 Jul;122(7):2590-600
19516261 - J Invest Dermatol. 2009 Oct;129(10):2351-7
9239834 - Vet Immunol Immunopathol. 1997 Jun;57(1-2):13-23
15626464 - Vet Immunol Immunopathol. 2005 Jan 10;103(1-2):83-92
10389638 - Exp Dermatol. 1999 Jun;8(3):204-11
18691918 - Vet J. 2009 Jun;180(3):348-55
22093101 - Clin Exp Allergy. 2012 Jan;42(1):144-55
16815144 - J Allergy Clin Immunol. 2006 Jul;118(1):98-104
References_xml – reference: 15. Mineshige, T., Kamiie, J., Sugahara, G., Yasuno, K., Aihara, N., Kawarai, S., Yamagishi, K., Shirota, M. and Shirota, K. 2015. Expression of Periostin in Normal, Atopic, and Nonatopic Chronically Inflamed Canine Skin. Vet. Pathol. 52: 1118–1126.
– reference: 3. Cork, M. J., Danby, S. G., Vasilopoulos, Y., Hadgraft, J., Lane, M. E., Moustafa, M., Guy, R. H., Macgowan, A. L., Tazi-Ahnini, R. and Ward, S. J. 2009. Epidermal barrier dysfunction in atopic dermatitis. J. Invest. Dermatol. 129: 1892–1908.
– reference: 11. Hvid, M., Vestergaard, C., Kemp, K., Christensen, G. B., Deleuran, B. and Deleuran, M. 2011. IL-25 in atopic dermatitis: a possible link between inflammation and skin barrier dysfunction? J. Invest. Dermatol. 131: 150–157.
– reference: 29. Yamaguchi, Y. 2014. Periostin in Skin Tissue and Skin-Related Diseases. Allergol. Int. 63: 161–170.
– reference: 26. Tsuchida, S., Bonkobara, M., McMillan, J. R., Akiyama, M., Yudate, T., Aragane, Y., Tezuka, T., Shimizu, H., Cruz, P. D. Jr. and Ariizumi, K. 2004. Characterization of Kdap, a protein secreted by keratinocytes. J. Invest. Dermatol. 122: 1225–1234.
– reference: 30. Zhou, H. M., Wang, J., Elliott, C., Wen, W., Hamilton, D. W. and Conway, S. J. 2010. Spatiotemporal expression of periostin during skin development and incisional wound healing: lessons for human fibrotic scar formation. J. Cell Commun. Signal. 4: 99–107.
– reference: 8. Fort, M. M., Cheung, J., Yen, D., Li, J., Zurawski, S. M., Lo, S., Menon, S., Clifford, T., Hunte, B., Lesley, R., Muchamuel, T., Hurst, S. D., Zurawski, G., Leach, M. W., Gorman, D. M. and Rennick, D. M. 2001. IL-25 induces IL-4, IL-5, and IL-13 and Th2-associated pathologies in vivo. Immunity 15: 985–995.
– reference: 2. Bentley, J. K., Chen, Q., Hong, J. Y., Popova, A. P., Lei, J., Moore, B. B. and Hershenson, M. B. 2014. Periostin is required for maximal airways inflammation and hyperresponsiveness in mice. J. Allergy Clin. Immunol. 134: 1433–1442.
– reference: 18. Olivry, T. and Mueller, R. S.International Task Force on Canine Atopic Dermatitis 2003. Evidence-based veterinary dermatology: a systematic review of the pharmacotherapy of canine atopic dermatitis. Vet. Dermatol. 14: 121–146.
– reference: 16. Morra, L. and Moch, H. 2011. Periostin expression and epithelial-mesenchymal transition in cancer: a review and an update. Virchows Arch. 459: 465–475.
– reference: 6. Egbert, M., Ruetze, M., Sattler, M., Wenck, H., Gallinat, S., Lucius, R. and Weise, J. M. 2014. The matricellular protein periostin contributes to proper collagen function and is downregulated during skin aging. J. Dermatol. Sci. 73: 40–48.
– reference: 22. Sinke, J. D., Thepen, T., Bihari, I. C., Rutten, V. P. and Willemse, T. 1997. Immunophenotyping of skin-infiltrating T-cell subsets in dogs with atopic dermatitis. Vet. Immunol. Immunopathol. 57: 13–23.
– reference: 21. Schlotter, Y. M., Rutten, V. P., Riemers, F. M., Knol, E. F. and Willemse, T. 2011. Lesional skin in atopic dogs shows a mixed Type-1 and Type-2 immune responsiveness. Vet. Immunol. Immunopathol. 143: 20–26.
– reference: 1. Abraham, D. J., Shiwen, X., Black, C. M., Sa, S., Xu, Y. and Leask, A. 2000. Tumor necrosis factor alpha suppresses the induction of connective tissue growth factor by transforming growth factor-beta in normal and scleroderma fibroblasts. J. Biol. Chem. 275: 15220–15225.
– reference: 17. Olivry, T. and Hill, P. B. 2001. The ACVD task force on canine atopic dermatitis (XVIII): histopathology of skin lesions. Vet. Immunol. Immunopathol. 81: 305–309.
– reference: 9. Gillan, L., Matei, D., Fishman, D. A., Gerbin, C. S., Karlan, B. Y. and Chang, D. D. 2002. Periostin secreted by epithelial ovarian carcinoma is a ligand for alpha(V)beta(3) and alpha(V)beta(5) integrins and promotes cell motility. Cancer Res. 62: 5358–5364.
– reference: 7. Elliott, C. G., Wang, J., Guo, X., Xu, S. W., Eastwood, M., Guan, J., Leask, A., Conway, S. J. and Hamilton, D. W. 2012. Periostin modulates myofibroblast differentiation during full-thickness cutaneous wound repair. J. Cell Sci. 125: 121–132.
– reference: 27. Wang, Y. H., Angkasekwinai, P., Lu, N., Voo, K. S., Arima, K., Hanabuchi, S., Hippe, A., Corrigan, C. J., Dong, C., Homey, B., Yao, Z., Ying, S., Huston, D. P. and Liu, Y. J. 2007. IL-25 augments type 2 immune responses by enhancing the expansion and functions of TSLP-DC-activated Th2 memory cells. J. Exp. Med. 204: 1837–1847.
– reference: 20. Rios, H., Koushik, S. V., Wang, H., Wang, J., Zhou, H. M., Lindsley, A., Rogers, R., Chen, Z., Maeda, M., Kruzynska-Frejtag, A., Feng, J. Q. and Conway, S. J. 2005. periostin null mice exhibit dwarfism, incisor enamel defects, and an early-onset periodontal disease-like phenotype. Mol. Cell. Biol. 25: 11131–11144.
– reference: 10. Gordon, E. D., Sidhu, S. S., Wang, Z. E., Woodruff, P. G., Yuan, S., Solon, M. C., Conway, S. J., Huang, X., Locksley, R. M. and Fahy, J. V. 2012. A protective role for periostin and TGF-β in IgE-mediated allergy and airway hyperresponsiveness. Clin. Exp. Allergy 42: 144–155.
– reference: 12. Maeda, S., Tsukui, T., Saze, K., Masuda, K., Ohno, K., Tsujimoto, H. and Iwabuchi, S. 2005. Production of a monoclonal antibody to canine thymus and activation-regulated chemokine (TARC) and detection of TARC in lesional skin from dogs with atopic dermatitis. Vet. Immunol. Immunopathol. 103: 83–92.
– reference: 4. Corren, J., Lemanske, R. F. Jr., Hanania, N. A., Korenblat, P. E., Parsey, M. V., Arron, J. R., Harris, J. M., Scheerens, H., Wu, L. C., Su, Z., Mosesova, S., Eisner, M. D., Bohen, S. P. and Matthews, J. G. 2011. Lebrikizumab treatment in adults with asthma. N. Engl. J. Med. 365: 1088–1098.
– reference: 25. Terada, Y., Nagata, M., Murayama, N., Nanko, H. and Furue, M. 2011. Clinical comparison of human and canine atopic dermatitis using human diagnostic criteria (Japanese Dermatological Association, 2009): proposal of provisional diagnostic criteria for canine atopic dermatitis. J. Dermatol. 38: 784–790.
– reference: 24. Takeshita, S., Kikuno, R., Tezuka, K. and Amann, E. 1993. Osteoblast-specific factor 2: cloning of a putative bone adhesion protein with homology with the insect protein fasciclin I. Biochem. J. 294: 271–278.
– reference: 5. Correa da Rosa, J., Malajian, D., Shemer, A., Rozenblit, M., Dhingra, N., Czarnowicki, T., Khattri, S., Ungar, B., Finney, R., Xu, H., Zheng, X., Estrada, Y. D., Peng, X., Suárez-Fariñas, M., Krueger, J. G. and Guttman-Yassky, E. 2015. Patients with atopic dermatitis have attenuated and distinct contact hypersensitivity responses to common allergens in skin. J. Allergy Clin. Immunol. 135: 712–720.
– reference: 28. Yagihara, H., Kinjo, E., Kobayashi, Y., Tsuji, A., Nishimura, Y., Shinozaki, N., Tamura, K., Isotani, M., Nakagaki, K., Takahashi, K., Ono, K., Washizu, T. and Bonkobara, M. 2009. Expression of canine Kdap in normal, hyperplastic and neoplastic epidermis. Vet. J. 180: 348–355.
– reference: 23. Takayama, G., Arima, K., Kanaji, T., Toda, S., Tanaka, H., Shoji, S., McKenzie, A. N., Nagai, H., Hotokebuchi, T. and Izuhara, K. 2006. Periostin: a novel component of subepithelial fibrosis of bronchial asthma downstream of IL-4 and IL-13 signals. J. Allergy Clin. Immunol. 118: 98–104.
– reference: 14. Masuoka, M., Shiraishi, H., Ohta, S., Suzuki, S., Arima, K., Aoki, S., Toda, S., Inagaki, N., Kurihara, Y., Hayashida, S., Takeuchi, S., Koike, K., Ono, J., Noshiro, H., Furue, M., Conway, S. J., Narisawa, Y. and Izuhara, K. 2012. Periostin promotes chronic allergic inflammation in response to Th2 cytokines. J. Clin. Invest. 122: 2590–2600.
– reference: 13. Marsella, R. and Girolomoni, G. 2009. Canine models of atopic dermatitis: a useful tool with untapped potential. J. Invest. Dermatol. 129: 2351–2357.
– reference: 19. Olivry, T., Dean, G. A., Tompkins, M. B., Dow, J. L. and Moore, P. F. 1999. Toward a canine model of atopic dermatitis: amplification of cytokine-gene transcripts in the skin of atopic dogs. Exp. Dermatol. 8: 204–211.
– ident: 3
  doi: 10.1038/jid.2009.133
– ident: 16
  doi: 10.1007/s00428-011-1151-5
– ident: 12
  doi: 10.1016/j.vetimm.2004.08.021
– ident: 5
  doi: 10.1016/j.jaci.2014.11.017
– ident: 24
  doi: 10.1042/bj2940271
– ident: 10
  doi: 10.1111/j.1365-2222.2011.03840.x
– ident: 17
  doi: 10.1016/S0165-2427(01)00305-1
– ident: 30
  doi: 10.1007/s12079-010-0090-2
– ident: 19
  doi: 10.1111/j.1600-0625.1999.tb00372.x
– ident: 23
  doi: 10.1016/j.jaci.2006.02.046
– ident: 29
  doi: 10.2332/allergolint.13-RAI-0685
– ident: 28
– ident: 7
  doi: 10.1242/jcs.087841
– ident: 9
– ident: 13
  doi: 10.1038/jid.2009.98
– ident: 20
– ident: 21
  doi: 10.1016/j.vetimm.2011.05.025
– ident: 26
– ident: 14
  doi: 10.1172/JCI58978
– ident: 22
  doi: 10.1016/S0165-2427(96)05763-7
– ident: 27
  doi: 10.1084/jem.20070406
– ident: 11
  doi: 10.1038/jid.2010.277
– ident: 15
– ident: 1
  doi: 10.1074/jbc.275.20.15220
– ident: 18
  doi: 10.1046/j.1365-3164.2003.00335.x
– ident: 4
  doi: 10.1056/NEJMoa1106469
– ident: 6
  doi: 10.1016/j.jdermsci.2013.08.010
– ident: 2
  doi: 10.1016/j.jaci.2014.05.029
– ident: 8
– ident: 25
– reference: 11754819 - Immunity. 2001 Dec;15(6):985-95
– reference: 22266908 - J Cell Sci. 2012 Jan 1;125(Pt 1):121-32
– reference: 21812663 - N Engl J Med. 2011 Sep 22;365(12 ):1088-98
– reference: 17635955 - J Exp Med. 2007 Aug 6;204(8):1837-47
– reference: 8363580 - Biochem J. 1993 Aug 15;294 ( Pt 1):271-8
– reference: 15140226 - J Invest Dermatol. 2004 May;122(5):1225-34
– reference: 9239834 - Vet Immunol Immunopathol. 1997 Jun;57(1-2):13-23
– reference: 10809757 - J Biol Chem. 2000 May 19;275(20):15220-5
– reference: 22684102 - J Clin Invest. 2012 Jul;122(7):2590-600
– reference: 19516261 - J Invest Dermatol. 2009 Oct;129(10):2351-7
– reference: 16815144 - J Allergy Clin Immunol. 2006 Jul;118(1):98-104
– reference: 18691918 - Vet J. 2009 Jun;180(3):348-55
– reference: 24996263 - J Allergy Clin Immunol. 2014 Dec;134(6):1433-1442
– reference: 22093101 - Clin Exp Allergy. 2012 Jan;42(1):144-55
– reference: 16314533 - Mol Cell Biol. 2005 Dec;25(24):11131-44
– reference: 20531985 - J Cell Commun Signal. 2010 Jun;4(2):99-107
– reference: 15626464 - Vet Immunol Immunopathol. 2005 Jan 10;103(1-2):83-92
– reference: 24759560 - Allergol Int. 2014 Jun;63(2):161-70
– reference: 20861853 - J Invest Dermatol. 2011 Jan;131(1):150-7
– reference: 19494826 - J Invest Dermatol. 2009 Aug;129(8):1892-908
– reference: 25755133 - Vet Pathol. 2015 Nov;52(6):1118-26
– reference: 12235007 - Cancer Res. 2002 Sep 15;62(18):5358-64
– reference: 24055232 - J Dermatol Sci. 2014 Jan;73(1):40-8
– reference: 21684616 - Vet Immunol Immunopathol. 2011 Sep 15;143(1-2):20-6
– reference: 21434981 - J Dermatol. 2011 Aug;38(8):784-90
– reference: 12791047 - Vet Dermatol. 2003 Jun;14(3):121-46
– reference: 10389638 - Exp Dermatol. 1999 Jun;8(3):204-11
– reference: 11553392 - Vet Immunol Immunopathol. 2001 Sep 20;81(3-4):305-9
– reference: 25583101 - J Allergy Clin Immunol. 2015 Mar;135(3):712-20
– reference: 21997759 - Virchows Arch. 2011 Nov;459(5):465-75
SSID ssj0021469
Score 2.225483
Snippet Atopic dermatitis (AD) is a chronic, pruritic, and allergic skin disease in humans and animals, particularly dogs. Canine AD (cAD) has received attention as a...
SourceID pubmedcentral
proquest
pubmed
crossref
jstage
SourceType Open Access Repository
Aggregation Database
Index Database
Enrichment Source
Publisher
StartPage 103
SubjectTerms Animal models
Animals
Atopic dermatitis
Cell Adhesion Molecules - genetics
Cell Adhesion Molecules - metabolism
Dermatitis, Atopic - metabolism
Dermatitis, Atopic - physiopathology
Dermatitis, Atopic - veterinary
DNA microarrays
dog
Dog Diseases - metabolism
Dog Diseases - pathology
Dogs
Female
Fibroblasts
Fibroblasts - metabolism
Gene Expression
Helper cells
Hybridization
Interleukin 13
Interleukin-13 - metabolism
Interleukin-17 - metabolism
interleukin-25
Keratinocytes
Keratinocytes - metabolism
Lymphocytes T
Male
Pathogenesis
Pathology
periostin
Polymerase chain reaction
RNA, Messenger - metabolism
Skin - metabolism
Skin - pathology
Skin diseases
Title A study on periostin involvement in the pathophysiology of canine atopic skin
URI https://www.jstage.jst.go.jp/article/jvms/80/1/80_17-0453/_article/-char/en
https://www.ncbi.nlm.nih.gov/pubmed/29176263
https://www.proquest.com/docview/2239616167
https://www.proquest.com/docview/1969936959
https://pubmed.ncbi.nlm.nih.gov/PMC5797867
Volume 80
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
ispartofPNX Journal of Veterinary Medical Science, 2018, Vol.80(1), pp.103-111
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwdV1Lb9QwEB6VwoELKuUVKJWR4IRSmpcdC1VVhagKaDmxqLfInrXLluKU7raCf8-M8xBbtZcoksdONOOxv_HjG4DXNAfPaot887dwaenL3dQ6ialEZ3RltM0rvig8-SqPpuXn4-p4DYZso70CFzeGdpxPanpxtvPn9999cvi9yI2g83enV78WOzTYEjop7sBdmpMUu-ikHPcTOHu17o-9X6_BdMAUszAry8rcdO-U4NmJuwl5Xj9A-d-MdLgBD3ooKQ462z-ENRc2YfM7n2-Jl2zFpN83fwSTAxF5ZEUbBFMbt-TYQcwDjU2RL3xJ74KgoOAExW1c7YjL7aL1gnRPbQgKzs_nKBY_5-ExTA8_fvtwlPaJFFKUMl-m5LbWWpOTJZS1qkRdlB5zl2WuzGrltZ9ZXcrcoPEFQSAyk8Nd9BYL5yvE4gmshza4ZyCQ4AZWWY052dUoZygk8XrmbaWMVGqWwNtBhQ32LOOc7OKs4WiDdN-w7ptMNaz7BN6M0ucdu8Ytcu87a4xSvV91UjVViY9Oeizki2vk_QlsDSZshg7WECzSkuCuVAm8GovJt3jDxATXXtLXtdSc8LDSCTztLD7-wNBnElArfWEUYN7u1ZIw_xH5uytFobtUz29t8wXcJ1xWdys9W7C-vLh0Lwn7LO02of5PX7Zj5_4HDp8JYA
linkProvider Scholars Portal
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=A+study+on+periostin+involvement+in+the+pathophysiology+of+canine+atopic+skin&rft.jtitle=Journal+of+veterinary+medical+science&rft.au=Mineshige%2C+Takayuki&rft.au=Kamiie%2C+Junichi&rft.au=Sugahara%2C+Go&rft.au=Shirota%2C+Kinji&rft.date=2018-01-01&rft.eissn=1347-7439&rft.volume=80&rft.issue=1&rft.spage=103&rft_id=info:doi/10.1292%2Fjvms.17-0453&rft_id=info%3Apmid%2F29176263&rft.externalDocID=29176263
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0916-7250&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0916-7250&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0916-7250&client=summon